NCT01922245View on ClinicalTrials.gov

tDCS and Aphasia Treatment

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Aphasia
Interventions
DEVICE

Soterix 1x1 tDCS

Anodal and sham tDCS will be administered. All of the participants will also receive behavioral speech-language therapy.

Trial Locations (1)

10010

Hunter College Brookdale Campus, New York

All Listed Sponsors
lead

Hunter College of City University of New York

OTHER

NCT01922245 - tDCS and Aphasia Treatment | Biotech Hunter | Biotech Hunter